Single-cell antigen-specific activation landscape of CAR T infusion product identifies determinants of CD19 positive relapse in patients with ALL
Z. Bai, S. Woodhouse, D. Kim, S. Lundh, H. Sun, Y. Deng, Y. Xiao, D. M. Barrett, R. M. Myers, S. A. Grupp, C. H. June, J. J. J. Joseph Melenhorst, P. G. Camara, R. Fan
The paper analyzes single-cell data from CAR T infusion products to identify factors associated with CD19-positive relapse in ALL patients.
bioRxiv · Apr 15, 2021Immunology